Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evogene Ltd Ord (NQ: EVGN )

1.800 -0.080 (-4.26%)
Streaming Delayed Price Updated: 3:00 PM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evogene Ltd Ord

< Previous 1 2 3 Next >
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present... 
Via Talk Markets
Evogene Offers An Excellent Risk/Reward Ratio
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... 
Via Talk Markets
Evogene 2022 Revenue Grows 80% To 1.7M
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) 2022 revenue was $1.7 million, an increase of 80% compared to $930,000 in 2021. Q4 Financial Highlights 
Via Benzinga
Evogene's Earnings Outlook
Via Benzinga
Canonic Launches Six Second-Generation Cannabis Products With Higher THC And Rich Terpene Profiles
Canonic Ltd., a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) launched six second-generation hybrid cannabis products in Israel. 
Via Benzinga
Evogene Q3 Revenue Grows 208% YoY, Here Are The Details
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized... 
Via Benzinga
Preview: Evogene's Earnings
Via Benzinga
Recap: Evogene Q4 Earnings
Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Scheduled For March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
Earnings Scheduled For November 17, 2022
Companies Reporting Before The Bell • Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million. 
Via Benzinga
Canonic Launches Its High THC Medical Cannabis Products In Israel
Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN), is launching its second-generation products in... 
Via Benzinga
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday. 
Via Benzinga
Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year. 
Via Benzinga
Earnings Scheduled For August 31, 2022
Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter. 
Via Benzinga
Earnings Outlook For Evogene
Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Wednesday, 2022-08-31. Here's what investors need to know before the announcement. Analysts estimate that Evogene will... 
Via Benzinga
ADDING MULTIMEDIA ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
From ICL Group LTD
Via Business Wire
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share. 
Via Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
 Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period... 
Via Benzinga
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending... 
Via Benzinga
Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt?
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter ended March 31, 2022, revealing revenue of $237,000 in comparison to $333,000 in the same period the... 
Via Benzinga
Evogene's Earnings: A Preview
Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that Evogene will report... 
Via Benzinga
Earnings Scheduled For May 26, 2022
Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
26 Stocks Moving in Thursday's Pre-Market Session
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:... 
Via Benzinga
Evogene Reports Wider Loss In 2021, $54M In Consolidated Cash
Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) announced its 
Via Benzinga
A Preview Of Evogene's Earnings
Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
Medical-Grade Cannabis Developer Canonic Appoints Ex-SEO At Israeli Ministry Of Health To Its Board
Medical-grade cannabis developer Canonic Ltd., and a wholly-owned subs... 
Via Benzinga
Computational Biology Company Evogene Confirms Earnings Results Release Date
Computational biology company Evogene Ltd. (NASDAQ:EVGN)&n... 
Via Benzinga
Evogene's Canonic Ships First Batch Of Unique Cannabis Varieties To Europe
Medical grade cannabis products developer Canonic Ltd. and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), has shipped the first batch of its unique cannabis varieties to Portugal, following... 
Via Benzinga
Certain Marijuana Varieties Have 'Impressive' Pain Relief Properties, Evogene's Cannonic's Pre-Clinical Study Confirms
Medical grade cannabis products developer Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ: 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.